Medical Devices Europe

Europe Mammography Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Europe Mammography Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $417.3 Mn Placeholder estimate
Estimate 2025 $444.9 Mn 17.3% of the global market
Projected 2034 $790.8 Mn 77.8% Adds $345.9 Mn over 9 forecast years
CAGR 2025–2034 6.6% Faster than 42% of 180 Medical Devices markets here
Key players 5
  • Europe is 17.34% of the global market.
  • Among regions, the largest is North America at $1.15 Bn.
  • Fastest growing: Africa at 9.7% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$345.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Mammography Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $417.3 Mn — —
2025 (base) $444.9 Mn +$27.5 Mn —
2026 (forecast) $474.2 Mn +$29.4 Mn +6.6%
2027 (forecast) $505.5 Mn +$31.3 Mn +13.6%
2028 (forecast) $538.9 Mn +$33.4 Mn +21.1%
2029 (forecast) $574.5 Mn +$35.6 Mn +29.1%
2030 (forecast) $612.4 Mn +$37.9 Mn +37.7%
2031 (forecast) $652.8 Mn +$40.4 Mn +46.7%
2032 (forecast) $695.9 Mn +$43.1 Mn +56.4%
2033 (forecast) $741.8 Mn +$45.9 Mn +66.7%
2034 (forecast) $790.8 Mn +$49.0 Mn +77.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Mammography Market Analysis at a glance
Market size, 2025$444.9 Mn placeholder estimate
Forecast, 2034$790.8 Mn placeholder estimate
Growth (CAGR), 2025–20346.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and setting (see all)
Key playersHologic, Inc., GE Healthcare, Siemens Healthineers, FUJIFILM Holdings Corporation, Planmed (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
Active clinical trials1,140 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 20 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Mammography Market Analysis Executive Summary

Mammography systems take low-dose X-ray images of the breast to find cancer early.

Key segments of the mammography market include product (2D Digital Mammography, 3D Tomosynthesis and Contrast-Enhanced Mammography) and setting (Hospitals, Breast Care Centers and Diagnostic Centers).

Bar chart: Europe Mammography market size, 2024–2034, placeholder estimates. $417.3 Mn in 2024, $444.9 Mn in 2025 and $790.8 Mn in 2034, 6.6% CAGR.
Europe Mammography market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Mammography Market Dynamics

Market Growth Drivers

More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the mammography market. Clinicians also use imaging earlier in care.

Opportunity

AI-assisted reading, compact systems for clinics and the replacement of old scanners give the mammography market room to grow.

Market Restraints

High equipment prices, a shortage of trained staff and long replacement cycles in public hospitals hold back the mammography market.

Competitive Landscape for Mammography Market in Europe

The mammography market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Mammography Market in Europe

Mammography in Europe: rules, payment and research

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6], MHRA (UK)⁠[7], IGJ (Netherlands)⁠[8], FAMHP (Belgium)⁠[9], Swissmedic (Switzerland)⁠[10], Läkemedelsverket (Sweden)⁠[11], Danish Medicines Agency (Denmark)⁠[12], URPL (Poland)⁠[13] and TITCK (Turkey)⁠[14]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[15] ClinicalTrials.gov lists 1,140 studies on Mammography that are recruiting, active or about to start in Europe.⁠[16]

[1] European Commission, medical devices. Checked 14 Nov 2026.

[2] ANSM, French medicines agency. Checked 14 Nov 2026.

[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.

[4] Italian Ministry of Health. Checked 14 Nov 2026.

[5] Roszdravnadzor. Checked 14 Nov 2026.

[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.

[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[8] Health and Youth Care Inspectorate (IGJ). Checked 19 Nov 2026.

[9] Federal Agency for Medicines and Health Products (FAMHP). Checked 19 Nov 2026.

[10] Swissmedic. Checked 19 Nov 2026.

[11] Swedish Medical Products Agency (Läkemedelsverket). Checked 19 Nov 2026.

[12] Danish Medicines Agency. Checked 19 Nov 2026.

[13] Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026.

[14] Turkish Medicines and Medical Devices Agency (TITCK). Checked 19 Nov 2026.

[15] European Commission, health technology assessment. Checked 14 Nov 2026.

[16] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 20 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how mammography products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Mammography right now, from free public sources.

Clinical trials

1,140 active trials in UK, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Denmark, Poland, Turkey and Russia

Recruiting, about to start, or running now. Counted across the 13 countries we report on in Europe.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Mammography in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Mammography market in Europe?
Placeholder estimate: about $444.9 Mn in 2025, rising to about $790.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Mammography market in Europe growing?
Placeholder estimate: about 6.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Mammography market report cover?
The report splits the market by product (2D Digital Mammography, 3D Tomosynthesis, Contrast-Enhanced Mammography) and setting (Hospitals, Breast Care Centers, Diagnostic Centers).
Who are the key players in the Mammography market?
Key players include Hologic, Inc., GE Healthcare, Siemens Healthineers, FUJIFILM Holdings Corporation and Planmed.
What is driving the Mammography market?
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the mammography market. Clinicians also use imaging earlier in care.
Who regulates Mammography in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Mammography are running in Europe?
1,140 studies are recruiting, active or about to start in Europe, counted across the 13 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 20 Nov 2026.
How much research is published on Mammography?
PubMed lists 7,524 papers on Mammography added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 20 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on imaging and oncology

See the topic